Food, Drugs, and Cosmetics - Gene Structure- and Function-Modifying Products - Labeling
Sponsor: Joanne C. Benson (District 24)Committee: FinanceSubject: Public HealthStatus: Unfavorable Report by Finance; Withdrawn (as of Sep 4, 2026)
What this bill does
Official synopsis
Prohibiting a person from offering for sale in the State a gene structure- or function-modifying product unless the product is labeled in a prominent and conspicuous manner with the words 'gene structure- or function-modifying product' and all potential risks, side effects, adverse effects, and other reasonably possible effects that the product may have; and establishing penalties for a violation of the Act.
AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (0)
MGA witness listNo witness list on file because no hearing has been scheduled.